Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses
Jiaxin Liu1,2, Jie Jia1,2, Chong Wang3
1School of Engineering Medicine Beihang University Beijing China.
Abstract:
As a leading cause of cancer-related morbidity and mortality worldwide, non-small cell lung cancer (NSCLC) is profoundly influenced by innate immune cells (IICs). In addition to serving as key mediators of antimicrobial defense and adaptive immune activation, IICs exert pivotal and multifaceted influences on the initiation, progression, and therapeutic responses of NSCLC. This review integrates current knowledge on the classification, phenotypic plasticity, and functions of IICs, as well as their crosstalk within the tumor microenvironment in NSCLC, summarizes therapeutic strategies targeting IICs, and discusses the existing challenges and future perspectives in NSCLC immunotherapy, to provide theoretical references for the immunotherapy of NSCLC.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
lncRNA - Long Non-coding RNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

